Clincosm LogoSign in Get a demo

myelodysplastic syndrome (mds)

Showing 26 - 50 of 77
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Myelodysplastic Syndrome (MDS) Trial in United States

Completed
  • Acute Myeloid Leukemia (AML)
  • +3 more
  • Phoenix, Arizona
  • +5 more
Mar 25, 2020

Myelodysplastic Syndrome (MDS) Trial run by the NHLBI (ON 01910 Na)

Completed
  • Myelodysplastic Syndrome (MDS)
  • ON 01910 Na
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 14, 2019

Allogeneic HCT Compared to Chemotherapy in Older AML Patients

Completed
Has Results
  • Acute Myeloid Leukemia (AML)
  • Myelodysplastic Syndrome (MDS)
    • Stanford, California
    • +11 more
    Nov 12, 2019

    Acute Myeloid Leukaemia (AML), Myelodysplastic Syndrome (MDS) Trial in Australia, France (S 055746)

    Completed
    • Acute Myeloid Leukaemia (AML)
    • Myelodysplastic Syndrome (MDS)
    • S 055746
    • Melbourne, Australia
    • +4 more
    May 22, 2019

    Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Chronic Myelomonocytic Leukemia (CMML) Trial in Baltimore

    Terminated
    • Acute Myeloid Leukemia (AML)
    • +2 more
    • Baltimore, Maryland
      Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
    Apr 18, 2019

    Myelodysplastic Syndrome (MDS) Trial in China (Azacitidine)

    Completed
    Has Results
    • Myelodysplastic Syndrome (MDS)
    • Beijing, China
    • +10 more
    Mar 4, 2019

    Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS) Trial in New York (Laromustine (VNP40101M) and Ara-C)

    Terminated
    • Acute Myeloid Leukemia (AML)
    • Myelodysplastic Syndrome (MDS)
    • Laromustine (VNP40101M) and Ara-C
    • New York, New York
      Weill Cornell Medical College
    Jan 25, 2019

    Myelodysplastic Syndrome (MDS) Trial in Belgium (Darbepoetin Alfa)

    Completed
    Has Results
    • Myelodysplastic Syndrome (MDS)
    • Darbepoetin Alfa
    • Charleroi, Belgium
    • +3 more
    Oct 15, 2018

    Myelodysplastic Syndrome (MDS) Trial in New York (T2* Cardiac and Liver MRI)

    Completed
    • Myelodysplastic Syndrome (MDS)
    • T2* Cardiac and Liver MRI
    • New York, New York
      Weill Medical College of Cornell University
    Oct 23, 2018

    Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML) Trial in France, Germany (drug, procedure, other, genetic)

    Terminated
    • Myelodysplastic Syndrome (MDS)
    • Acute Myeloid Leukemia (AML)
    • Nantes, France
    • +9 more
    Oct 23, 2018

    Myelodysplastic Syndrome (MDS), Chronic Myelogenous Leukemia, Acute Lymphoblastic Leukemia Trial run by the NHLBI (Stem Cell

    Completed
    • Myelodysplastic Syndrome (MDS)
    • +4 more
    • Stem Cell Transplantation
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Jul 3, 2018

    Leukemia, Acute, Chronic Myelogenous Leukemia (CML), Myelodysplastic Syndrome (MDS) Trial in Stanford (Regulatory T-cells,

    Terminated
    Has Results
    • Leukemia, Acute
    • +6 more
    • Regulatory T-cells
    • +6 more
    • Stanford, California
      Stanford University School of Medicine
    Jun 1, 2018

    Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS) Trial in Pittsburgh (5-azacytidine (5-aza) maintenance therapy

    Withdrawn
    • Acute Myeloid Leukemia (AML)
    • Myelodysplastic Syndrome (MDS)
    • 5-azacytidine (5-aza) maintenance therapy after transplant
    • Pittsburgh, Pennsylvania
      University of Pittsburgh Medical Center
    Mar 29, 2018

    Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Myelodysplastic Syndrome (MDS) Trial in United States

    Withdrawn
    • Acute Myeloid Leukemia (AML)
    • +2 more
    • Los Angeles, California
    • +4 more
    Mar 12, 2018

    Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Myelodysplastic Syndrome (MDS) Trial in United States

    Completed
    Has Results
    • Acute Myeloid Leukemia (AML)
    • +2 more
    • Indianapolis, Indiana
    • +4 more
    Oct 23, 2017

    Myelodysplastic Syndrome (MDS) Trial (CDA-2 (Cell Differentiation Agent 2))

    Unknown status
    • Myelodysplastic Syndrome (MDS)
    • CDA-2 (Cell Differentiation Agent 2)
    • (no location specified)
    Nov 4, 2017

    Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS) Trial in Memphis (Cytarabine, Intrathecal Triples, HPC-A)

    Terminated
    Has Results
    • Acute Myeloid Leukemia (AML)
    • Myelodysplastic Syndrome (MDS)
    • Memphis, Tennessee
      St. Jude Children's Research Hospital
    Oct 4, 2017

    Myelodysplastic Syndrome (MDS) Trial in Germany (LBH589, Epoetin Alfa)

    Terminated
    Has Results
    • Myelodysplastic Syndrome (MDS)
    • Mannheim, Baden-Württemberg, Germany
    • +11 more
    Aug 8, 2017

    Myelodysplastic Syndrome (MDS) Trial run by the NHLBI (WT1 and PR1 Peptide Vaccine)

    Completed
    • Myelodysplastic Syndrome (MDS)
    • WT1 and PR1 Peptide Vaccine
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Jun 30, 2017

    Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome (MDS) Trial in Kansas City (Administration of

    Completed
    Has Results
    • Acute Myeloid Leukemia
    • +4 more
    • Administration of hyperbaric oxygen
    • Kansas City, Kansas
      University of Kansas Medical Center
    May 9, 2017

    Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML), Myeloid Sarcoma Trial in Memphis (Cyclophosphamide,

    Terminated
    Has Results
    • Acute Lymphoblastic Leukemia (ALL)
    • +6 more
    • Memphis, Tennessee
      St. Jude Children's Research Hospital
    Apr 24, 2017

    Leukemia, Acute Myelogenous (AML), Leukemia, Acute Lymphocytic (ALL), Leukemia, Chronic Myelogenous (CML) Trial run by the NCI

    Completed
    Has Results
    • Leukemia, Acute Myelogenous (AML)
    • +4 more
    • WT1 Peptide-Pulsed Dendritic Cells
    • +7 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Mar 1, 2017

    For Donors, Related Donors Giving Peripheral Blood Stem Cells (PBSC) to a Sibling, For Recipients Trial in United States

    Terminated
    • For Donors
    • +9 more
    • Los Angeles, California
    • +7 more
    Apr 6, 2017

    Chronic Kidney Disease, Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL) Trial in Boston (Haploidentical Bone

    Unknown status
    • Chronic Kidney Disease
    • +16 more
    • Haploidentical Bone Marrow/Kidney
    • Boston, Massachusetts
      Massachusetts General Hospital
    Mar 21, 2017

    Myelodysplastic Syndrome (MDS), Aplastic Anaemia (AA), Myelofibrosis (MF) Trial in Singapore (Chinese herbal concoction twice a

    Completed
    • Myelodysplastic Syndrome (MDS)
    • +3 more
    • Chinese herbal concoction twice a day for 6 months
    • Singapore, Singapore
      Singapore General Hospital
    Feb 9, 2017